[ Price : $8.95]
Federal Register notice: FDA issues a final rule to amend its regulations to address the use of master files by applications licen...[ Price : $8.95]
FDA accepts for priority review a Lykos Therapeutics NDA for midomafetamine capsules used in combination with psychological interv...[ Price : $8.95]
FDA makes available a draft guidance entitled FDA Advanced Manufacturing Technologies Designation Program.[ Price : $8.95]
Federal Register notice: FDA announces a 5/20-21 public workshop entitled FY 2024 Generic Drug Science and Research Initiatives Wo...[ Price : $8.95]
FDA convenes a 2/13 advisory committee meeting to discuss the clinical significance of Abbott Medicals TRILUMINATE pivotal trial t...[ Price : $8.95]
FDA clears a Proscia 510(k) for its Concentriq AP-Dx, a diagnostic software for pathologists for viewing, interpreting, and managi...[ Price : $8.95]
FDA removes a clinical hold against Hemogenyx Pharmaceuticals IND for the companys chimeric antigen receptor T-cells therapy for t...[ Price : $8.95]
FDA approves a Takeda NDA for Eohilia (budesonide oral suspension), indicated for treating eosinophilic esophagitis.